S6 - E4 - Reasons for optimism in MASLD drug development and patient advocacy

Send us a text This is the second half of Roger Green's conversation with Dimitar Tonev. It focuses largely on some of the elements of Stephen's personality that made him so unique and a role model within the community. Dimitar discusses one more innovation Stephen brought to MASLD clinical trials: recruiting in neighborhoods that received lower levels of medical care and then, within those communities, recruiting within families. Roger harkens back to the recruitment issue to tell the...

26 Touko 202415min

Send us a text The conversation shares the first half of Roger Green's interview with Dimitar Tonev, whose tribute comment to Stephen Roger shared in a recent SurfingMASH weekly newsletter. Because this is Dimitar's first appearance on SurfingMASH, he starts by telling the audience a bit about his history, including the fact that he came to know Stephen from the viral hepatitis days. As his "one unique thing," Dimitar mentions his proficiency as a skier, which leads Roger to ask about ...

25 Touko 202411min

Send us a text This conversation includes the second half of Jörn Schattenberg's and Roger Green's interview with Donna Cryer. It focuses largely on Stephen's inclusive approaches towards bringing stakeholders to pivotal discussions. Donna starts this conversation by noting an important thing she learned early in her career: when patients, advocates and physicians work together, their collective power is far more than the sum of their individual impacts. She commends Stephen as one KOL...

25 Touko 20249min

Send us a text This conversation includes the first half of Jörn Schattenberg's and Roger Green's interview with Donna Cryer. While the question is about Stephen's most outstanding contribution to MASLD, the focus is more on his remarkable ability to trigger increased awareness of MASH in many different ways. Roger starts the conversation by asking Jörn and Donna to describe one outstanding contribution (okay, maybe two) that Stephen made to the field of MASLD. Jörn talks about Stephen's rol...

25 Touko 202410min

Send us a text Global Liver Institute Founder and CEO Donna Cryer and hepatology researcher and industry executive Dimitar Tonev join Jörn Schattenberg and Roger Green to share memories of our co-founder and MASLD leader Stephen Harrison. 00:00:00 - Surf's Up: Season 5 Episode 16 Standard lead-in, including quotes from panelists 00:02:55 - Introduction Roger describes the structure of this episode. 00:04:04 - Conversation with Donna and Jörn, including groundbreakers Goo...

23 Touko 202448min

Send us a text This week's vault looks back to SurfingMASH's Barcelona coverage in earlier years to identify one point we can use to evaulate progress in the field. In this case, we looked back one year to see that INCBCN focus on NITs was driven largely by work from NAIL-NIT. Specifically, the 2023 version of NIT coverage at #SLDThinkTank 2024 was a discussion of real-world data from NAIL-NIT. The original conversation has a robust description: Surfing NASH returns to review the 2023 Innovat...

19 Touko 202411min

Send us a text This wrap-up conversation focuses on elements to add and reconsider for #SLDThinkTank 2025. One key concept was to broaden the set of stakeholders invited to participate. Another involved focusing on the broader idea of "preventive hepatology." This conversation starts with Roger Green asking the group what other topics from #SLDThinkTank 2024 the panel should discuss before closing. Jörn Schattenberg expresses the hope that future meetings will have a wider representati...

19 Touko 202414min

Send us a text This conversation from #SLDThinkTank 2024 focuses largely on ways to improve delivery of screening services to patients. Along the way, participants reflect on the value of having Rezdiffra approved in the US and on its way to approval in other markets. As the conversation starts, Mike Betel transitions from a broader discussion of prevention to note that there are 94 FibroScan devices for all of Canada. Even these 94 are severely underutilized! Maja Thiele states that h...

19 Touko 202413min